XRX
52
-3
LH
48
-2
HON
47
-12
WU
12
-4
NRG
69
12
PFE
30
-3
EIX
69
3
FAST
46
-3
FLS
56
-3
C
60
-2
HP
41
-4
PLD
51
-5
SJM
38
-3
NTRS
49
-5
TRIP
66
5
VZ
47
2
PCAR
50
-3
L
55
-4
PRGO
44
-2
DE
53
8
XRX
52
-3
LH
48
-2
HON
47
-12
WU
12
-4
NRG
69
12
PFE
30
-3
EIX
69
3
FAST
46
-3
FLS
56
-3
C
60
-2
HP
41
-4
PLD
51
-5
SJM
38
-3
NTRS
49
-5
TRIP
66
5
VZ
47
2
PCAR
50
-3
L
55
-4
PRGO
44
-2
DE
53
8
Financhill
Back

Daktronics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
33

DAKT
Daktronics

Last Price:
12.15
Seasonality Move:
8.27%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
33
Daktronics (DAKT) is a Sell

Is Daktronics a Buy, Sell or Hold?

  • The current Daktronics [DAKT] share price is $12.10. The Score for DAKT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • DAKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DAKT Stock Price Chart

What is Daktronics's stock price today?

  • The Daktronics share price today is $12.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAKT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

DAKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 35.9 Sell
Chaikin Money Flow: -749542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.1 - 15.06) Sell
Bollinger Bands (100): (11.13 - 14.49) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

DAKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.37 Sell
20-day SMA: 13.17 Sell
50-day SMA: 14.01 Sell
200-day SMA: 10.72 Buy
8-day EMA: 12.38 Sell
20-day EMA: 12.93 Sell
50-day EMA: 13.3 Sell
200-day EMA: 11.35 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Daktronics Earnings Growth & DAKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.79 per share, and a decrease next year of $0.09 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Daktronics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):